188
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors

, , , , , & show all
Pages 766-769 | Received 03 Mar 2017, Accepted 09 Jul 2017, Published online: 09 Aug 2017
 

Compliance with ethical approval process

The Low Dose TKI study has been reviewed and approved by the Ethical and Scientific review board of the Inserm Clinical Research Center 1402, on 23 July 2015. The registration number of the study is ‘M15-33’.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/doi:10.1080/10428194.2017.1357178.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.